Evidence coverage: One AJCN meta-analysis pooling 14 randomized trials of glucomannan (konjac fibre) across lipid, glucose, weight and blood-pressure endpoints.
A fibre that nudges the scale and moves cholesterol. certainty: Moderate (meta-analysis of small randomized trials)
Pooled randomized trials show glucomannan reduces body weight by about 0.8 kg — statistically significant but marginal — while its stronger, better-replicated effect sits on blood lipids.
- Body weight WMD −0.79 kg (95% CI −1.53 to −0.05) across 14 trials (source-reported)
- Total cholesterol −19.3 mg/dL and LDL −16.0 mg/dL — the better-evidenced effects (source-reported)
- Paediatric, dietary-modification and impaired-glucose subgroups benefited less (source-reported)
- Trials are small and dated; the CI barely excludes zero (source-reported)
Konjac products carry a real choking hazard when swallowed dry: take with a full glass of water, every time — and fibre GI effects are common at loading doses.